VALIDATION OF PRODUCTION AND PACKAGING PROCESS OF CANNABIS OIL 25:25 THC:CBD (25MG/ML THC: 25MG/ML CBD)

Abstract

Validation of manufacturing processes is a critical element within Good Manufacturing Practice (GMP), particularly in the production of products containing pharmacologically active substances such as the oil derived from *Cannabis sativa L.*. The chemical complexity of the plant, together with regulatory restrictions, necessitates the systematic establishment and demonstration of reproducible and controlled manufacturing conditions.
This study aims to present a framework for the validation of critical steps in the production and packaging of cannabis oil 25:25 THC:CBD (25 mg/mL THC : 25 mg/mL CBD), thereby defining and establishing standards and parameters which can subsequently be considered reproducible and applicable for every subsequent batch of production and packaging of the final product.
A GMP-oriented methodology was applied, including: identification of critical control points, establishment of acceptable limits for heating, scaling, mixing with heating, filling, labeling, and packaging. To conduct this study, three validation series were produced.
The results of the validated process testing confirmed that the production and packaging process complies with the quality specification. Furthermore, compliance was ensured with pharmacopeial requirements regarding residual solvents, pesticides, heavy metals, and microbiological purity.
Validation of the process for cannabis oil production represents an essential prerequisite for ensuring the quality, safety, and efficacy of the final product. Standardization of manufacturing steps and strict control of critical parameters provide the foundation for regulatory compliance and support the clinical application of cannabis-based medicinal products.
The production and packaging process of cannabis oil 25:25 THC:CBD (25 mg/mL THC : 25 mg/mL CBD) can be further developed with additional approaches and long-term modifications to the already established framework, with the aim of improving and simplifying the process, while maintaining the primary goal of achieving a high-quality, effective, and safe product.
The manufacturing and packaging process of 25:25 THC:CBD cannabis oil (25 mg/mL THC : 25 mg/mL CBD) may be further optimized through additional and innovative approaches in the long term, with the overall goal of improving and simplifying the process to ensure a high-quality, effective, and safe product. Furthermore, continuous monitoring and iterative improvement of the process will allow adaptation to evolving regulatory standards and emerging scientific knowledge. Such efforts will ultimately contribute to broader clinical availability and patient access to standardized, reliable cannabis-based therapies.